Drug class in one race

Serotonin 5-HT2A receptor (antagonist / inverse agonist) drugs for Schizophrenia

2 tracked Serotonin 5-HT2A receptor (antagonist / inverse agonist) drugs in the Schizophrenia race. The class explanation lives on the Serotonin 5-HT2A receptor (antagonist / inverse agonist) page; the full indication pipeline across every mechanism is on the Schizophrenia page.

1 Phase 31 Phase 1

Head-to-head evidence: LY03017 vs Roluperidone

The roster

← all Serotonin 5-HT2A receptor (antagonist / inverse agonist) drugs